
Albert Bourla
PersonHeard in 5 episodes across 2 shows since Nov 2025
Albert Bourla is a Greek-American pharmaceutical executive who has served as chairman and chief executive officer of Pfizer, overseeing the company during the COVID-19 vaccine and antiviral rollout.
Episodes
First heard
Guest appearances
Episodes per month
Public PodLume episodes featuring it, over the last year.
Show the data
| Month | Episodes |
|---|---|
| Nov 2025 | 2 |
| Dec 2025 | 1 |
| Jan 2026 | 1 |
| Feb 2026 | 0 |
| Mar 2026 | 0 |
| Apr 2026 | 0 |
| May 2026 | 0 |
| Jun 2026 | 0 |
| Jul 2026 | 0 |
| Aug 2026 | 0 |
| Sep 2026 | 1 |
| Oct 2026 | 0 |
Email alert
Email me when Albert Bourla comes up on a podcast
One email a week at most, with the new episodes that mention Albert Bourla. Free, no account needed, unsubscribe in one click.
What Albert Bourla has said on podcasts
11 statements
Pfizer will start ten Phase 3 obesity studies in 2026.
“We are going to start 10 phase three studies this year.”
Open the episode · Mad Money w/ Jim Cramer 1/12/26Listen at 25:49
Pfizer expects its ultra-long-acting GLP-1 to be highly differentiated.
“we hope to demonstrate how highly differentiated the ultra-long-acting GLP-1 it is compared to the long-acting GLP-1s of the others.”
Open the episode · Mad Money w/ Jim Cramer 1/12/26Listen at 26:09
Pfizer expects to play a significant role in obesity treatment.
“we will be able to play a very significant role.”
Open the episode · Mad Money w/ Jim Cramer 1/12/26Listen at 27:01
Statements are attributed to the speaker as said on the episode and reflect their view at the time, not PodLume's. They are not advice.
Episodes
5 episodes featuring Albert Bourla, newest first
- Sep 13, 2026
Biotech’s rally tests the promise of cancer breakthroughsWSJ's Take On the WeekSep 13, 2026 - Jan 13, 2026
Healthcare CEOs pitch obesity drugs and device breakthroughsMad Money w/ Jim CramerJan 13, 2026Guest - Dec 5, 2025
Cramer weighs enterprise AI against steadier betsMad Money w/ Jim CramerDec 5, 2025 - Nov 11, 2025
Cramer weighs AI momentum against health care and quantum betsMad Money w/ Jim CramerNov 11, 2025 - Nov 6, 2025
GE’s breakup, chip consolidation and Axon’s AI betMad Money w/ Jim CramerNov 6, 2025